Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage company developing therapies for metabolic and endocrine disorders, announced on September 22, 2026 topline results from the VK2735-102…
September 22, 2026
March 13, 2024
Marijuana-Consuming Rodents Disrupt New Orleans Police Evidence Storage: “They’re all high.”
In an unusual turn of events, rodents with a penchant for cannabis have been discovered consuming marijuana evidence in the deteriorating evidence room of the…
February 28, 2024
Bone Cancer: Rare Disease Taking a Share of the Biotech Spotlight
Bone cancer is rare, making up just one percent of all cancer cases. Despite advances in treatment for other cancers, the standard of care for…
February 20, 2024
Federal Probe Targets Generic Drug Shortages: A Path to Stabilizing Essential Medication Supply
The Federal Trade Commission (FTC) and the Department of Health and Human Services (HHS) have launched an inquiry into the shortages of generic drugs, focusing…